Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Cardiovascular Imaging Reports
Published in: Current Cardiovascular Imaging Reports 9/2015

01-09-2015 | Cardiac Computed Tomography (TC Villines, Section Editor)

Transcaval TAVR—What the Radiologist Needs to Know

Authors: Shehbaz Shaikh, Thomas Song, Dee Dee Wang, Nick Reeser, Adam Greenbaum, William O’Neill

Published in: Current Cardiovascular Imaging Reports | Issue 9/2015

Login to get access

Abstract

Transcaval transcatheter aortic valve replacement is a new approach in performing percutaneous aortic valve replacement in which aortic access is obtained by way of the femoral vein and inferior vena cava. Computed tomographic angiography is used to determine patient suitability and in preprocedural planning. CTA is also part of routine follow-up care to assess for potential caval-aortic access site complications. Postprocedural imaging findings at the caval-aortic site include aortocaval fistula, aortic dissection, retroperitoneal hemorrhage, and pseudoaneurysm. The purpose of this manuscript is to familiarize the reader with the technical aspects of this new procedure and the periprocedural assessment of the caval-aortic access site with CTA.
Literature
1.
Otto CM, Prendergast B. Aortic-valve stenosis—from patients at risk to severe valve obstruction. N Engl J Med. 2014;371:744–56.CrossRefPubMed
2.
Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686–95.CrossRefPubMed
3.
Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;367:1697–704.
4.
Walther T, Blumenstein J, Van Linden A, et al. Contemporary management of aortic stenosis: surgical aortic valve replacement remains the gold standard. Heart. 2012;98:23–9.CrossRef
5.
Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8.CrossRefPubMed
6.••
Halabi M, Ratnayaka K, Faranesh AZ, et al. Aortic access from the vena cava for large caliber transcatheter cardiovascular interventions. J Am Coll Cardiol. 2013;61:1745–6. This article was the first to describe transcaval access for valve replacement in an animal model.
7.
Godoy MCB, Cayne NS, Ko JP. Endovascular repair of the thoracic aorta preoperative and postoperative evaluation with multidetector computed tomography. J Thorac Imaging. 2011;26:63–73.CrossRefPubMed
8.••
Greenbuam AB, O’Neill WW, Paone G, et al. Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients. J Am Coll Cardiol. 2014;63:2795–804. This article was the first to describe transcaval TAVR in man and reports patient demographics and clinical outcomes in a series of the first 19 patients.
9.
Godart F, Haulon S, Houmany M, et al. Transcatheter closure of aortocaval fistula with the Amplatzer duct occluder. J Endovasc Ther. 2005;12:134–7.CrossRefPubMed
10.
LaBarbera M, Nathanson D, Hui P. Percutaneous closure of aortocaval fistula using the Amplatzer muscular VSD occluder. J Invasive Cardiol. 2011;23:343–4.PubMed
11.
Loh PH, Jensen T, Søndergaard L. Percutaneous closure of congenital aortocaval fistula with a coexisting secundum atrial septal defect. Cardiol Young. 2012;4:472–4.CrossRef
12.
Apfaltrer P, Henzler T, Blanke P, Krazinski AW, et al. Computed tomography for planning transcatheter aortic valve replacement. J Thorac Imaging. 2013;28:231–9.CrossRefPubMed
13.
Bloomfield GS, Gillam LD, Hahn RT, et al. A practical guide to multimodality imaging of transcatheter aortic valve replacement. J Am Coll Cardiol Img. 2012;5:441–55.CrossRef
14.
Saldago RA, Leipsic JA, Shivalkar B, et al. Preprocedural CT evaluation of transcatheter aortic valve replacement: what the radiologist needs to know. RadioGraphics. 2014;34:1491–514.CrossRef
15.••
Lederman RJ, Chen MY, Rogers T, et al. Planning transcaval access using CT for large transcatheter implants. J Am Coll Cardiol Img. 2014;7:1167–71. This article provides a detailed review of the preprocedural evaluation for patients undergoing transcaval TAVR.
16.
Saad NEA, Saad WE, Davies MG, et al. Pseudoaneurysms and the role of minimally invasive techniques in their management. RadioGraphics. 2005;25:S173–89.CrossRefPubMed
Metadata
Title
Transcaval TAVR—What the Radiologist Needs to Know
Authors
Shehbaz Shaikh
Thomas Song
Dee Dee Wang
Nick Reeser
Adam Greenbaum
William O’Neill
Publication date
01-09-2015
Publisher
Springer US
Published in
Current Cardiovascular Imaging Reports / Issue 9/2015
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-015-9352-y

Other articles of this Issue 9/2015

Current Cardiovascular Imaging Reports 9/2015 Go to the issue

Specific Populations and Emerging Markets (V Dilsizian and T. Schindler, Section Editors)

An Increasing Mexican Population with Metabolic Syndrome-Emerging Role of Hybrid SPECT/CT and PET/CT in Cardiovascular Disease Detection

Cardiac Computed Tomography (TC Villines, Section Editor)

Cardiac CT in 2015: Clinical Role According to Current Multi-Societal Guidelines

Echocardiography (T Buck, Section Editor)

Hybrid Imaging During Transcatheter Structural Heart Interventions

Cardiac Computed Tomography (TC Villines, Section Editor)

Cardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease Events

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits